| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |